Arkolith/Insider Trading/CRDF/Form 4

White Lale

DirectorCardiff Oncology, Inc. (CRDF) · full profile →Form 4 · filed Jul 6, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 5, 2022Option exercise(M)29K$2.60$75K99K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 5, 2022Option exercise(M)29K$2.60$75K61K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-22-018607) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML